Intervention Review

You have free access to this content

Screening for peripheral arterial disease

  1. Alina Andras1,*,
  2. Bart Ferket2

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 7 APR 2014

Assessed as up-to-date: 19 NOV 2013

DOI: 10.1002/14651858.CD010835.pub2


How to Cite

Andras A, Ferket B. Screening for peripheral arterial disease. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD010835. DOI: 10.1002/14651858.CD010835.pub2.

Author Information

  1. 1

    Freeman Hospital, Northern Vascular Centre, Newcastle upon Tyne, UK

  2. 2

    Erasmus MC, Depts. of Epidemiology and Radiology, Rotterdam, Netherlands

*Alina Andras, Northern Vascular Centre, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK. alinaro@hotmail.com. alina.andras@nuth.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 APR 2014

SEARCH

 
Characteristics of excluded studies [ordered by study ID]

StudyReason for exclusion

Behar 2013Single arm study of diabetic outpatients

Bergiers 2011Observational study

Delgado-OsorioSingle arm study

Farkas 2012Observational study

Kravos 2009Observational study, one arm screened population

Mourad 2009Observational study

Taylor-Piliae 2011Cross-sectional study, screened population only

 
Characteristics of ongoing studies [ordered by study ID]
Viborg 2014

Trial name or titleRandomised preventive vascular screening trial of 65 - 74 year old men in the central region of Denmark

MethodsAllocation: Randomised
Endpoint classification: Efficacy study
Intervention model: Parallel assignment
Masking: Single blind (investigator)
Primary purpose: Screening

ParticipantsMales: aged 65 - 74 years

Inclusion criteria:

  • men aged 65 - 74 years old living in the central region of Denmark


Exclusion criteria:

  • men not aged 65 - 74 years
  • men aged 65 - 74 years old not living in the central region of Denmark

InterventionsProcedure: Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm Invited to vascular screening

  • Experimental: Invited to screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm
  • No intervention: Participants who are not offered vascular screening

OutcomesPrimary outcomes:

- All-cause mortality at 3, 5 and 10 years

Secondary outcomes:

- Cardiovascular events at 3, 5 and 10 years

Starting dateSeptember 2008

Contact informationJes S Lindholt, MD PhD

+45 89272447; email: Jes.S.Lindholt@Viborg.RM.DK

Eskild W Henneberg, MD

+45 89272445; email: Eskild.W.Henneberg@Viborg.RM.DK

NotesThe investigators were contacted in November 2013. No results are available yet for this study.